Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer

  • The PLOS ONE Staff

Correction: Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer

  • The PLOS ONE Staff
PLOS
x

There are errors in the names and affiliations for the fourth and fifth authors. The correct names and affiliations should appear as shown here:

Christoph Q. Schmidt3, Andreas Wortmann4

3 Institute of Pharmacology of Natural Products & Clinical Pharmacology, Ulm University, Ulm, Germany

4 Tierforschungszentrum, Ulm University, Ulm, Germany

The correct citation is: Lucas T, Benihoud K, Vigant F, Schmidt C, Wortmann A, Bachem MG, et al. (2015) Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer. PLoS ONE 10(2): e0117254. doi:10.1371/journal.pone.0117254

Reference

  1. 1. Lucas T, Benihoud K, Vigant F, Schmidt CQA, Bachem MG, Simmet T, et al. (2015) Hexon Modification to Improve the Activity of Oncolytic Adenovirus Vectors against Neoplastic and Stromal Cells in Pancreatic Cancer. PLoS ONE 10(2): e0117254. pmid:25692292